Cargando…

Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)

BACKGROUND: TAFI is a plasma protein assumed to be an important link between coagulation and fibrinolysis. The three-dimensional crystal structures of authentic mature bovine TAFI (TAFIa) in complex with tick carboxypeptidase inhibitor, authentic full lenght bovine plasma thrombin-activatable fibrin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valnickova, Zuzana, Thaysen-Andersen, Morten, Højrup, Peter, Christensen, Trine, Sanggaard, Kristian W, Kristensen, Torsten, Enghild, Jan J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684115/ https://www.ncbi.nlm.nih.gov/pubmed/19416536 http://dx.doi.org/10.1186/1471-2091-10-13

Ejemplares similares

Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021)

Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission
por: ERDOĞAN, Mehmet, et al.
Publicado: (2019)

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
por: Kraft, Peter, et al.
Publicado: (2010)

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
por: Kim, Hyun Kyung
Publicado: (2010)

Dose-Response Relationship Between Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) and Stroke: A Chinese Case-Control Study
por: Dai, Huixu, et al.
Publicado: (2017)

Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis
por: Park, Rojin, et al.
Publicado: (2010)

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
por: Sotos, Katherine E., et al.
Publicado: (2023)

Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis
por: Hayakawa, M, et al.
Publicado: (2011)

Data supporting the structural and functional characterization of Thrombin‐Activatable Fibrinolysis Inhibitor in breast cancer
por: Fawzy, Manal S., et al.
Publicado: (2015)

Thrombin-Activatable Fibrinolysis Inhibitor Polymorphisms and Cerebral Venous Thrombosis in Mexican Mestizo Patients
por: Arauz, Antonio, et al.
Publicado: (2018)

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
por: Eser, Mehmet, et al.
Publicado: (2012)

Thrombin activatable fibrinolysis inhibitor as a bleeding predictor in liver transplantation: a pilot observational study
por: Nedel, Wagner Luis, et al.
Publicado: (2016)

Increased Thrombin-Activatable Fibrinolysis Inhibitor and Decreased Tissue Factor Pathway Inhibitor and Thrombomodulin Levels in Children with Hypothyroidism
por: Alioğlu, Bülent, et al.
Publicado: (2012)

Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor
por: Ito, Yusuke, et al.
Publicado: (2018)

A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
por: Stanne, Tara M., et al.
Publicado: (2018)

Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study
por: Fawzy, Manal S., et al.
Publicado: (2015)

A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction
por: Zhao, Mengnan, et al.
Publicado: (2022)

Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)
por: Schreuder, Herman, et al.
Publicado: (2016)

Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion
por: Fang, Ping, et al.
Publicado: (2021)

VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow
por: van Moorsel, Marc V. A., et al.
Publicado: (2022)

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
por: Bazzi, Zainab A., et al.
Publicado: (2016)

Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes
por: Huang, Qinghua, et al.
Publicado: (2023)

Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene
por: Karring, Henrik, et al.
Publicado: (2007)

Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
por: Ranucci, Marco, et al.
Publicado: (2020)

Alternative SET/TAFI Promoters Regulate Embryonic Stem Cell Differentiation
por: Edupuganti, Raghu Ram, et al.
Publicado: (2017)

Ratiometric Activatable Cell-Penetrating Peptides Provide Rapid In Vivo Readout of Thrombin Activation**
por: Whitney, Michael, et al.
Publicado: (2013)

Characterisation of protein families in spider digestive fluids and their role in extra-oral digestion
por: Walter, André, et al.
Publicado: (2017)

Identification of Genes and miRNAs Associated with TAFI-Related Thrombosis: An in Silico Study
por: Rouka, Erasmia, et al.
Publicado: (2023)

Näthähu de ga kähä, de ga t'afi = empáchense de tunas y de miel
por: Bernal Pérez, Filipino
Publicado: (2015)

Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2021)

Proteomics of Fuchs’ Endothelial Corneal Dystrophy Support That the Extracellular Matrix of Descemet’s Membrane Is Disordered
por: Poulsen, Ebbe Toftgaard, et al.
Publicado: (2014)

Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors
por: Kang, Hyo Jin, et al.
Publicado: (2008)

Post-Traumatic Sepsis Is Associated with Increased C5a and Decreased TAFI Levels
por: Vollrath, Jan Tilmann, et al.
Publicado: (2020)

An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature
por: Totoki, Takaaki, et al.
Publicado: (2022)

The subunit composition of human extracellular superoxide dismutase (EC-SOD) regulate enzymatic activity
por: Petersen, Steen V, et al.
Publicado: (2007)

Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging
por: Lagrange, Jérémy, et al.
Publicado: (2017)

The unresolved safety concerns of bovine thrombin
por: Shander, Aryeh, et al.
Publicado: (2008)

Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms
por: Bridge, Katherine, et al.
Publicado: (2017)

Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets
por: Du, Xiao-Yan, et al.
Publicado: (2009)

Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population
por: Li, You, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4lo1n7q6sa32ep5n5kgn7okdb7